Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics

Journal of Medical Microbiology

Volumn 61, Issue PART 9, 2012, Pages 1194-1207

  Tiago, F C P ^a   Martins, F S ^a   Souza, E L S ^a   Pimenta, P F P ^b   Araujo, H R C ^b   Castro, I M ^c   Brandao R L ^c   Nicoli, Jacques R ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; MANNOSE; PROBIOTIC AGENT; RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ADHERENCE; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM LONGUM; CELL WALL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS TYPE A; CONTROLLED STUDY; DIGESTIVE SYSTEM; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FUNGAL STRAIN; FUNGAL VIABILITY; FUNGUS MUTANT; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; LACTOBACILLUS DELBRUECKII; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYPLOIDY; PRIORITY JOURNAL; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SCANNING ELECTRON MICROSCOPY; SHIGELLA SONNEI; SPECIES INVASION; VIBRIO CHOLERAE;

ANIMALS; BACTERIAL ADHESION; CELL WALL; ESCHERICHIA COLI; HUMANS; INTESTINES; MICE; MICE, INBRED NOD; PROBIOTICS; SACCHAROMYCES; SALMONELLA TYPHIMURIUM;

EID: 84865240144     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.042283-0     Document Type: Article

References (39)

1. Boyle, R. J., Robins-Browne, R. M. & Tang, M. L. K. (2006). Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83, 1256-1264.
2. Brandão, R. L., Castro, I. M., Bambirra, E. A., Amaral, S. C., Fietto, L. G., Tropia, M. J. M., Neves, M. J., Dos Santos, R. G., Gomes, N. C. M. & Nicoli, J. R. (1998). Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Environ Microbiol 64, 564-568.
3. Buts, J. P., Bernasconi, P., Vaerman, J. P. & Dive, C. (1990). Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci 35, 251-256.
4. Castagliuolo, I., Riegler, M. F., Valenick, L., LaMont, J. T. & Pothoulakis, C. (1999). Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun 67, 302-307.
5. Ciriello, C. J. & Lachance, M. A. (2001). YEASTCOMPARE. London, ON, Canada: University of Western Ontario.
6. COBEA (2006). Colegio Brasileiro de Experimentação Animal. Legislação e Ética. http://www.cobea.org.br/.
7. Cusumano, C. K. & Hultgren, S. J. (2009). Bacterial adhesion-a source of alternate antibiotic targets. IDrugs 12, 699-705.
8. Czerucka, D., Roux, I. & Rampal, P. (1994). Saccharomyces boulardii inhibits secretagogue-mediated adenosine 39,59-cyclic monophosphate induction in intestinal cells. Gastroenterology 106, 65-72.
9. Czerucka, D., Dahan, S., Mograbi, B., Rossi, B. & Rampal, P. (2000). Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 68, 5998-6004.
10. Dahan, S., Dalmasso, G., Imbert, V., Peyron, J.-F., Rampal, P. & Czerucka, D. (2003). Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 71, 766-773. FAO/WHO (2002). Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, ON, Canada: Food and Agriculture Organization/World Health Organization.
11. FAO/WHO (2002). Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, ON, Canada: Food and Agriculture Organization/World Health Organization.
12. Gedek, B. R. (1999). Adherence of Escherichia coli serogroup O 157 and the Salmonella Typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 42, 261-264.
13. Generoso, S. V., Viana, M., Santos, R., Martins, F. S., Machado, J. A., Arantes, R. M., Nicoli, J. R., Correia, M. I. & Cardoso, V. N. (2010). Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol 192, 477-484.
14. Gómez-Zavaglia, A., Kociubinski, G., Pérez, P., Disalvo, E. & De Antoni, G. (2002). Effect of bile on the lipid composition and surface properties of bifidobacteria. J Appl Microbiol 93, 794-799.
15. Guglielmetti, S., Tamagnini, I., Minuzzo, M., Arioli, S., Parini, C., Comelli, E. & Mora, D. (2009). Study of the adhesion of Bifidobacterium bifidum MIMBb75 to human intestinal cell lines. Curr Microbiol 59, 167-172.
16. Jain, S., Yadav, H., Sinha, P. R., Naito, Y. & Marotta, F. (2008). Dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei has a protective effect against Salmonella enteritidis infection in mice. Int J Immunopathol Pharmacol 21, 1021-1029.
17. Jain, S., Yadav, H. & Sinha, P. R. (2009). Probiotic dahi containing Lactobacillus casei protects against Salmonella enteritidis infection and modulates immune response in mice. J Med Food 12, 576-583.
18. Kline, K. A., Fälker, S., Dahlberg, S., Normark, S. & Henriques-Normark, B. (2009). Bacterial adhesins in host-microbe interactions. Cell Host Microbe 5, 580-592.
19. Korhonen, T. K. (1979). Yeast agglutination of purified enterobacterial pili. FEMS Microbiol 6, 421-425.
20. Korhonen, T. K., Leffler, H. & Svanborg Edén, C. (1981). Binding specificity of piliated strains of Escherichia coli and Salmonella Typhimurium to epithelial cells, Saccharomyces cerevisiae cells, and erythrocytes. Infect Immun 32, 796-804.
21. Kovacs, D. J. & Berk, T. (2000). Recurrent Clostridium difficileassociated diarrhea and colitis treated with Saccharomyces cerevisiae (Baker's yeast) in combination with antibiotic therapy: a case report. J Am Board Fam Pract 13, 138-140.
22. Kumura, H., Tanoue, Y., Tsukahara, M., Tanaka, T. & Shimazaki, K. (2004). Screening of dairy yeast strains for probiotic applications. J Dairy Sci 87, 4050-4056.
23. Lachance, M.-A., Bowles, J. M., Starmer, W. T. & Barker, J. S. F. (1999). Kodamaea kakaduensis and Candida tolerans, two new ascomycetous yeast species from Australian hibiscus flowers. Can J Microbiol 45, 172-177.
24. Martins, F. S., Nardi, R. M. D., Arantes, R. M. E., Rosa, C. A., Neves, M. J. & Nicoli, J. R. (2005). Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J Gen Appl Microbiol 51, 83-92.
25. Martins, F. S., Rodrigues, A. C. P., Tiago, F. C. P., Penna, F. J., Rosa, C. A., Arantes, R. M. E., Nardi, R. M. D., Neves, M. J. & Nicoli, J. R. (2007). Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol 56, 352-359.
26. Martins, F. S., Veloso, L. C., Arantes, R. M. & Nicoli, J. R. (2009). Effects of yeast probiotic formulation on viability, revival and protection against infection with Salmonella enterica ssp. enterica serovar Typhimurium in mice. Lett Appl Microbiol 49, 738-744.
27. Martins, F. S., Dalmasso, G., Arantes, R. M. E., Doye, A., Lemichez, E., Lagadec, P., Imbert, V., Peyron, J. F., Rampal, P. & other authors (2010). Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection. PLoS ONE 5, e8925.
28. Martins, F. S., Elian, S. D. A., Vieira, A. T., Tiago, F. C. P., Martins, A. K. S., Silva, F. C. P., Souza, E. L. S., Sousa, L. P., Araújo, H. R. C. & other authors (2011). Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever. Int J Med Microbiol 301, 359-364.
29. Pérez-Sotelo, L. S., Talavera-Rojas, M., Monroy-Salazar, H. G., Lagunas-Bernabé, S., Cuarón-Ibargüengoytia, J. A., Jimenez, R. M. & Vázquez-Chagoyán, J. C. (2005). In vitro evaluation of the binding capacity of Saccharomyces cerevisiae Sc47 to adhere to the wall of Salmonella spp. Rev Latinoam Microbiol 47, 70-75.
30. Pimenta, P. F. & De Souza, W. (1986). Cytochemical localization of acid phosphatase in Leishmania mexicana amazonensis. J Submicrosc Cytol 18, 127-132.
31. Pleasants, J. R. (1974). Gnotobiotics. In Handbook of Laboratory Animal Science, pp. 119-174. Edited by E. C. Melby, Jr & N. H. Altmann. Cleveland, OH: CRC Press.
32. Qamar, A., Aboudola, S., Warny, M., Michetti, P., Pothoulakis, C., LaMont, J. T. & Kelly, C. P. (2001). Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect Immun 69, 2762-2765.
33. Rodrigues, A. C. P., Nardi, R. M., Bambirra, E. A., Vieira, E. C. & Nicoli, J. R. (1996). Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. J Appl Bacteriol 81, 251-256.
34. Rodrigues, A. C., Cara, D. C., Fretez, S. H. G. G., Cunha, F. Q., Vieira, E. C., Nicoli, J. R. & Vieira, L. Q. (2000). Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 89, 404-414.
35. Silva, L. M., Carvalho Botelho, A. C., Nacif-Pimenta, R., Martins, G. F., Alves, L. C., Brayner, F. A., Fortes-Dias, C. L. & Pimenta, P. F. (2008). Structural analysis of the venom glands of the armed spider Phoneutria nigriventer (Keyserling, 1891): microanatomy, fine structure and confocal observations. Toxicon 51, 693-706.
36. Stratford, M. (1993). Yeast flocculation: flocculation onset and receptor availability. Yeast 9, 85-94.
37. Truusalu, K., Mikelsaar, R. H., Naaber, P., Karki, T., Kullisaar, T., Zilmer, M. & Mikelsaar, M. (2008). Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC Microbiol 8, 132.
38. van der Aa Kühle, A., Skovgaard, K. & Jespersen, L. (2005). In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. Int J Food Microbiol 101, 29-39.
39. Vieira, L. Q., dos Santos, L. M., Neumann, E., da Silva, A. P., Moura, L. N. & Nicoli, J. R. (2008). Probiotics protect mice against experimental infections. J Clin Gastroenterol 42 (Suppl. 3 Pt 2), S168-S169.